title: Autocrine growth factors as therapeutic targets in lung cancer.
authors.affiliation: NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Md. 20892.
authors.forename: J L
authors.initials: JL
authors.lastname: Mulshine
authors.forename: A M
authors.initials: AM
authors.lastname: Treston
authors.forename: R B
authors.initials: RB
authors.lastname: Natale
authors.forename: P G
authors.initials: PG
authors.lastname: Kasprzyk
authors.forename: I
authors.initials: I
authors.lastname: Avis
authors.forename: Y
authors.initials: Y
authors.lastname: Nakanishi
authors.forename: F
authors.initials: F
authors.lastname: Cuttitta
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001839:Bombesin / Q000037:antagonists & inhibitors; D002986:Clinical Trials as Topic; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D019886:Gastrin-Releasing Peptide; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006133:Growth Substances; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000037:antagonists & inhibitors; D008175:Lung Neoplasms / Q000628:therapy*; D010455:Peptides / Q000037:antagonists & inhibitors; D014168:Transferrin / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D006131:Growth Inhibitors; D006133:Growth Substances; D010455:Peptides; D014168:Transferrin; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D019886:Gastrin-Releasing Peptide; D001839:Bombesin